Gene transfer into hematopoietic cells

Stem Cells

Volumn 15, Issue SUPPL. 1, 1997, Pages 123-134

  Nienhuis, Arthur W ^a   Bertran, Joan ^a   Hargrove, Phillip ^a   Vanin, Elio ^a,b   Yang, Yanping ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Adeno associated virus; Erythroid cell; Globin gene; Receptor; Retrovirus; Stem cell; Vector

Indexed keywords

VIRUS VECTOR;

CONFERENCE PAPER; ERYTHROID CELL; GENE EXPRESSION; GENE INSERTION; GENE TRANSFER; HEMATOPOIETIC CELL; MURINE LEUKEMIA VIRUS; REPRODUCIBILITY; STEM CELL;

ANIMALS; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GLOBINS; HEMATOPOIETIC STEM CELLS; HUMANS; VIRUSES;

ADENO-ASSOCIATED VIRUS; ANIMALIA; MURINAE; MURINE LEUKEMIA VIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0030716458     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.5530150816     Document Type: Article

References (85)

1. Dunbar CE. Gene transfer into hematopoietic stem cells: amplifications for gene therapy of human disease. Annu Rev Med 1996;47:11-20.
2. Brenner MK. Gene transfer to hematopoietic cells. N Engl J Med 1996;335:337-339.
3. Poeschla E, Corbeau P, Wong-Staal F. Development of HIV vectors for anti-HIV gene therapy. Proc Natl Acad Sci USA 1996;93:11395-11399.
4. Roth JA, Cristiano RJ. Gene therapy for cancer: what have we done and where are we going? J Natl Cancer Inst 1997;89:21-39.
5. Miller AD, Miller DG, Garcia JV et al. Use of retroviral vectors for gene transfer and expression. Methods Enzymol 1993;217:581-599.
6. Williams DA, Lemischka IR, Nathan DG et al. Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse. Nature 1984;310:476-480.
7. v mice. Cell 1985;42:71-79.
8. Lemischka IR, Raulet DH, Mulligan RC. Developmental potential and dynamic behavior of hematopoietic stem cells. Cell 1986;45:917-927.
9. Markowitz D, Goff S, Bank A. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J Virol 1988;62:1120-1124.
10. Danos O, Mulligan RC. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci USA 1988;85:6460-6464.
11. Donahue RE, Kessler SW, Bodine D et al. Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med 1992;176:1125-1135.
12. Brenner MK, Rill DR, Holladay MS et al. Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 1993;342:1134-1137.
13. Dunbar CE, Cottler-Fox M, O'Shaughnessy JA et al. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 1995;85:3048-3057.
14. Kohn DB, Weinberg KI, Nolta JA et al. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat Med 1995;1:1017-1023.
15. Dunbar CE, Seidel NE, Doren S et al. Improved retroviral gene transfer into murine and Rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor. Proc Natl Acad Sci USA 1996;93:11871-11876.
16. von Melchner H, Housman DE. The expression of neomycin phosphotransferase in human promyelocytic leukemia cells (HL60) delays their differentiation. Oncogene 1988;2:137-140.
17. Riddell SR, Elliott M, Lewinsohn DA et al. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat Med 1996;2:216-223.
18. Kavanaugh MP, Miller DG, Zhang W et al. Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc Natl Acad Sci USA 1994;91:7071-7075.
19. Albritton LM, Kim JW, Tseng L Envelope-binding domain in the cationic amino acid transporter determines the host range of ecotropic murine retroviruses. J Virol 1993;67:2091-2096.
20. Orlic D, Girard LJ, Jordan CT et al. The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction. Proc Natl Acad Sci USA 1996;93:11097-11102.
21. Springett GM, Moen RC, Anderson S et al. Infection efficiency of T lymphocytes with amphotropic retroviral vectors is cell cycle dependent. J Virol 1989;63:3865-3869.
22. Miller DG, Adam MA, Miller AD. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 1990;10:4239-4242.
23. Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood 1993;81:2844-2853.
24. Yonemura Y, Ku H, Lyman SD et al. In vitro expansion of hematopoietic progenitors and maintenance of stem cells: comparison between FLT3/FLK-2 ligand and KIT ligand. Blood 1997;89:1915-1921.
25. Bodine DM, Karlsson S, Nienhuis AW. Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hematopoietic stem cells. Proc Natl Acad Sci USA 1989;86:8897-8901.
26. Luskey BD, Rosenblatt M, Zsebo K et al. Stem cell factor, interleukin-3, and interleukin-6 promote retroviral-mediated gene transfer into murine hematopoietic stem cells. Blood 1992;80:396-402.
27. Fraser CC, Eaves CJ, Szilvassy SJ et al. Expansion in vitro of retrovirally marked totipotent hematopoietic stem cells. Blood 1990;76:1071-1076.
28. Soma T, Yu JM, Dunbar CE. Maintenance of murine long-term repopulating stem cells in ex vivo is affected by modulation of transforming growth factor-beta but not macrophage inflammatory protein-1 alpha activities. Blood 1996;87:4561-4567.
29. Hughes PF, Eaves CJ, Hogge DE et al. High-efficiency gene transfer to human hematopoietic cells maintained in long-term marrow culture. Blood 1989;74:1915-1922.
30. Moore KA, Deisseroth AB, Reading CL et al. Stromal support enhances cell-free retroviral vector transduction of human bone marrow long-term culture-initiating cells. Blood 1992;79:1393-1399.
31. Hanenberg H, Xiao XL, Dilloo D et al. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nat Med 1996;2:876-882.
32. Moritz T, Dutt P, Xiao X et al. Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: evidence of direct viral binding to chymotryptic carboxy-terminal fragments. Blood 1996;88:855-862.
33. Bensinger WI, Berenson RJ, Andrews RG et al. Positive selection of hematopoietic progenitors from marrow and peripheral blood for transplantation. J Clin Apheresis 1990;5:74-76.
34. Baum CM, Weissman IL, Tsukamoto AS et al. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA 1992;89:2804-2808.
35. Craig W, Kay R, Cutler RB et al. Expression of Thy-1 on human hematopoietic progenitor cells. J Exp Med 1993;177:1331-1342.
36. Nolta JA, Kohn DB. Comparison of the effects of growth factors on retroviral vector-mediated gene transfer and the proliferative status of human hematopoietic progenitor cells. Hum Gene Ther 1990;1:257-268.
37. Cassel A, Cottler-Fox M, Doren S et al. Retroviral-mediated gene transfer into CD34-enriched human peripheral blood stem cells. Exp Hematol 1993;21:585-591.
38. Larochelle A, Vormoor J, Hanenberg H et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med 1996;2:1329-1337.
39. Bodine DM, McDonagh KT, Seidel NE et al. Survival and retrovirus infection of murine hematopoietic stem cells in vitro: effects of 5-FU and method of infection. Exp Hematol 1991;19:206-212.
40. Bodine DM, Seidel NE, Gale MS et al. Efficient retrovirus transduction of mouse pluripotent hematopoietic stem cells mobilized into the peripheral blood by treatment with granulocyte colony-stimulating factor and stem cell factor. Blood 1994;84:1482-1491.
41. Bodine DM, Seidel NE, Orlic D. Bone marrow collected 14 days after in vivo administration of granulocyte colony-stimulating factor and stem cell factor to mice has 10-fold more repopulating ability than untreated bone marrow. Blood 1996;88:89-97.
42. Kyoizumi S, Baum CM, Kaneshima H et al. Implantation and maintenance of functional human bone marrow in SCID-hu mice. Blood 1992;79:1704-1711.
43. Nolta JA, Hanley MB, Kohn DB. Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: analysis of gene transduction of long-lived progenitors. Blood 1994;83:3041-3051.
44. Bock TA, Orlic D, Dunbar CE et al. Improved engraftment of human hematopoietic cells in severe combined immunodeficient (SCID) mice carrying human cytokine transgenes. J Exp Med 1995;182:2037-2043.
45. Dick JE. Normal and leukemic human stem cells assayed in SCID mice. Semin Immunol 1996;8:197-206.
46. + bone marrow cells. Blood 1993;82:1975-1980.
47. van Beusechem VW, Kukler A, Heidt PJ et al. Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone-marrow cells. Proc Natl Acad Sci USA 1992;89:7640-7644.
48. Carter RF, Abrams-Ogg AC, Dick JE et al. Autologous transplantation of canine long-term marrow culture cells genetically marked by retroviral vectors. Blood 1992;79:356-364.
49. Schuening FG, Kawahara K, Miller AD et al. Retrovirus-mediated gene transduction into long-term repopulating marrow cells of dogs. Blood 1991;78:2568-2576.
50. Bienzle D, Abrams-Ogg AC, Kruth SA et al. Gene transfer into hematopoietic stem cells: long-term maintenance of in vitro activated progenitors without marrow ablation. Proc Natl Acad Sci USA 1994;91:350-354.
51. Rill DR, Santana VM, Roberts WM et al. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 1994;84:380-383.
52. Brenner MK, Rill DR, Moen RC et al. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993;341:85-86.
53. + cell present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 1994;83:3068-3076.
54. Cornetta K, Srour EF, Moore A et al. Retroviral gene transfer in autologous bone marrow transplantation for adult acute leukemia. Hum Gene Ther 1996;7:1323-1329.
55. Bordigon C, Notarangelo LD, Nobili N et al. Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients. Science 1995;270:470-475.
56. Yang Y, Vanin EF, Whitt M et al. Inducible, high level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein. Hum Gene Ther 1995;6:1203-1213.
57. Naldini L, Blomer U, Gallay P et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996;272:263-267.
58. Muzyczka N. Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr Top Microbiol Immunol 1992;158:97-129.
59. Kotin RM. Prospects for use of adeno-associated virus as a vector for human gene therapy. Hum Gene Ther 1994;5:793-801.
60. Flotte TR, Carter BJ. Adeno-associated virus vectors for gene therapy. Gene Ther 1995;2:357-362.
61. Rolling F, Samulski RJ. AAV as a viral vector for human gene therapy: generation of recombinant virus. Mol Biotechnol 1995;3:9-15.
62. Chiorini JA, Wendtner CM, Urcelay E et al. High-efficiency transfer of the T-cell co-stimulatory molecule B7-2 to lymphoid cells using high-liter recombinant adeno-associated virus vectors. Hum Gene Ther 1995;6:1531-1541.
63. Clark KR, Voulgaropoulou F, Fraley DM et al. Cell lines for the production of recombinant adeno-associated virus. Hum Gene Ther 1995;6:1329-1341.
64. Tamayose K, Hirai Y, Shimada T. A new strategy for large scale preparation of high liter recombinant adeno-associated virus (AAV) vectors by using packaging cell lines and sulfonated cellulose column chromatography. Hum Gene Ther 1996;7:507-513.
65. Miller JL, Donahue RE, Sellers SE et al. Recombinant adeno-associated virus (rAAV) mediated expression of a human γ-globin gene in human progenitor derived erythroid cells. Proc Natl Acad Sci USA 1994;91:10183-10187.
66. Xiao X, Li J, Samulski RJ. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vectors. J Virol 1996;70:8098-8108.
67. Fisher KJ, Jooss K, Alston J et al. Recombinant adeno-associated virus for muscle directed gene therapy. Nat Med 1997;3:306-312.
68. Kaplitt MG, Leone P, Samulski RJ et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 1994;8:148-154.
69. Flotte TR, Afione SA, Conrad C et al. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc Natl Acad Sci USA 1993;90:10613-I0617.
70. Podaskoff G, Wong Jr KK., Chatterjee S. Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors. J Virol 1994;68:5656-5666.
71. Russell DW, Miller AD, Alexander IE. Adeno-associated virus vectors preferentially transduce cells in S phase. Proc Natl Acad Sci USA 1994;91:8915-8919.
72. Fisher KJ, Cao G-P, Weitzman MD et al. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J Virol 1996;70:520-532.
73. Ferrari FK, Samulski T, Shenk T et al. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J Virol 1996;70:3227-3234.
74. Hermonat PL, Muzyczka N. Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. Proc Natl Acad Sci USA 1984;81:6466-6470.
75. Lebkowski JS, McNally MN, Okarma TB et al. Adeno-associated virus: a vector system for efficient introduction and integration of DNA into a variety of mammalian cell types. Mol Cell Biol 1988;8:3988-3996.
76. Walsh CE, Liu JM, Xiao X et al. Regulated high level expression of a human gamma-globin gene introduced into erythroid cells by an adeno-associated virus vector. Proc Natl Acad Sci USA 1992;89:7257-7261.
77. Bertran J, Miller JL, Yang Y et al. Recombinant adeno-associated virus-mediated high-efficiency, transient expression of the murine cationic amino acid transporter (ecotropic retroviral receptor) permits stable transduction of human HeLa cells by ecotropic retroviral vectors. J Virol 1996;70:6759-6766.
78. Leboulch P, Huang GM, Humphries RK et al. Mutagenesis of retroviral vectors transducing human beta-globin gene and beta-globin locus control region derivatives results in stable transmission of an active transcriptional structure. EMBO J 1994;13:3065-3076.
79. Sadelain M, Wang CH, Antoniou M et al. Generation of a high-liter retroviral vector capable of expressing high levels of the human beta-globin gene. Proc Natl Acad Sci USA 1995;92:6728-6732.
80. McCune SL, Townes TM. Retroviral vector sequences inhibit human beta-globin gene expression in transgenic mice. Nucleic Acids Res 1994;22:4477-4481.
81. Miller JL, Walsh CE, Ney PA et al. Single-copy transduction and expression of human γ-globin in K562 erythroleukemia cells using recombinant adeno-associated virus vectors: the effect of mutations in NF-E2 and GATA-1 binding motifs within the hypersensitivity site 2 enhancer. Blood 1993;82:1900-1906.
82. Hargrove P, Vanin EF, Kurtzman G et al. High level globin gene expression mediated by a recombinant adeno-associated virus genome which contains the 3′ γ globin gene regulatory element and integrates as tandem copies in erythroid cells. Blood 1997;89:2167-2175.
83. Russell DW, Alexander IE, Miller AD. DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors. Proc Natl Acad Sci USA 1995;92:5719-5723.
84. Halbert CL, Alexander IE, Wolgamot GM et al. Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells. J Virol 1995;69:1473-1479.
85. Weitzman MD, Kyostio SR, Kotin R et al. Adenoassociated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA. Proc Natl Acad Sci USA 1994;91:5808-5812.